Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis

Abstract Background To discriminatively evaluate the cost-saving effects of a disease management program for diabetic nephropathy patients through care process rectification and, subsequently, improved health outcomes. Methods This study links public medical insurance claims data to the health recor...

Full description

Bibliographic Details
Main Authors: Hiroyuki Kawaguchi, Michiko Moriyama, Hideki Hashimoto
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Health Services Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12913-020-05297-0
id doaj-98643ca757574e869b14aac505cebb2e
record_format Article
spelling doaj-98643ca757574e869b14aac505cebb2e2020-11-25T03:15:33ZengBMCBMC Health Services Research1472-69632020-05-0120111010.1186/s12913-020-05297-0Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysisHiroyuki Kawaguchi0Michiko Moriyama1Hideki Hashimoto2Seijo University, Faculty of EconomicsClinical Nursing Research Laboratory, Chronic Care and Family Nursing Unit, Hiroshima University, Graduate School of Biomedical & Health SciencesDepartment of Health and Social Behavior, The University of Tokyo, School of Public HealthAbstract Background To discriminatively evaluate the cost-saving effects of a disease management program for diabetic nephropathy patients through care process rectification and, subsequently, improved health outcomes. Methods This study links public medical insurance claims data to the health records of a disease management program for diabetic nephropathy patients. To account for selection bias caused by the non-randomized allocation of the disease management program for diabetes patients, we adopted a fixed-effect model of panel data analysis. To discriminatively evaluate the cost-saving effects of the disease management program for diabetic nephropathy patients through care process rectification and, subsequently, improved health outcomes, we expanded the difference-in-differences analysis from the traditional two-period model to a three-period model, comprising the before-intervention, during-intervention, and after-intervention periods. Data were extracted from municipal public insurers in Kure, Japan. Results The cost-reduction effect in terms of treatment costs from the before-intervention period to the during-intervention period (the rectification effect) was 4.02%, and the cost-saving effect from the during-intervention period to the after-intervention period (the health improvement effect) was 2.95%. Conclusions A disease management program for diabetes patients organized by local public insurers in Japan reduced costs both by amending treatment processes and by subsequently improving the prognosis of the disease.http://link.springer.com/article/10.1186/s12913-020-05297-0Disease managementDiabetesDialysisDifference-in-differences analysisCharlson comorbidity index
collection DOAJ
language English
format Article
sources DOAJ
author Hiroyuki Kawaguchi
Michiko Moriyama
Hideki Hashimoto
spellingShingle Hiroyuki Kawaguchi
Michiko Moriyama
Hideki Hashimoto
Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
BMC Health Services Research
Disease management
Diabetes
Dialysis
Difference-in-differences analysis
Charlson comorbidity index
author_facet Hiroyuki Kawaguchi
Michiko Moriyama
Hideki Hashimoto
author_sort Hiroyuki Kawaguchi
title Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
title_short Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
title_full Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
title_fullStr Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
title_full_unstemmed Does disease management for diabetic nephropathy reduce medical expenditure? Evidence from a three-period difference-in-differences analysis
title_sort does disease management for diabetic nephropathy reduce medical expenditure? evidence from a three-period difference-in-differences analysis
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2020-05-01
description Abstract Background To discriminatively evaluate the cost-saving effects of a disease management program for diabetic nephropathy patients through care process rectification and, subsequently, improved health outcomes. Methods This study links public medical insurance claims data to the health records of a disease management program for diabetic nephropathy patients. To account for selection bias caused by the non-randomized allocation of the disease management program for diabetes patients, we adopted a fixed-effect model of panel data analysis. To discriminatively evaluate the cost-saving effects of the disease management program for diabetic nephropathy patients through care process rectification and, subsequently, improved health outcomes, we expanded the difference-in-differences analysis from the traditional two-period model to a three-period model, comprising the before-intervention, during-intervention, and after-intervention periods. Data were extracted from municipal public insurers in Kure, Japan. Results The cost-reduction effect in terms of treatment costs from the before-intervention period to the during-intervention period (the rectification effect) was 4.02%, and the cost-saving effect from the during-intervention period to the after-intervention period (the health improvement effect) was 2.95%. Conclusions A disease management program for diabetes patients organized by local public insurers in Japan reduced costs both by amending treatment processes and by subsequently improving the prognosis of the disease.
topic Disease management
Diabetes
Dialysis
Difference-in-differences analysis
Charlson comorbidity index
url http://link.springer.com/article/10.1186/s12913-020-05297-0
work_keys_str_mv AT hiroyukikawaguchi doesdiseasemanagementfordiabeticnephropathyreducemedicalexpenditureevidencefromathreeperioddifferenceindifferencesanalysis
AT michikomoriyama doesdiseasemanagementfordiabeticnephropathyreducemedicalexpenditureevidencefromathreeperioddifferenceindifferencesanalysis
AT hidekihashimoto doesdiseasemanagementfordiabeticnephropathyreducemedicalexpenditureevidencefromathreeperioddifferenceindifferencesanalysis
_version_ 1724638847867813888